Narasimha R. Krishnamurthy
Bengaluru, KA, India
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 11 publications
Discovery of CA-4948, an Orally Bioavailable IRAK4 Inhibitor for Treatment of Hematologic Malignancies.
Journal: ACS medicinal chemistry letters
Published: May 13, 2020
Structure of cyclin-dependent kinase 2 (CDK2) in complex with the specific and potent inhibitor CVT-313.
Journal: Acta crystallographica. Section F, Structural biology communications
Published: May 09, 2020
Correction to "Selective PPARδ Modulators Improve Mitochondrial Function: Potential Treatment for Duchenne Muscular Dystrophy (DMD)".
Journal: ACS medicinal chemistry letters
Published: June 22, 2019
Selective PPARδ Modulators Improve Mitochondrial Function: Potential Treatment for Duchenne Muscular Dystrophy (DMD).
Journal: ACS medicinal chemistry letters
Published: June 23, 2018
Novel highly selective peroxisome proliferator-activated receptor δ (PPARδ) modulators with pharmacokinetic properties suitable for once-daily oral dosing.
Journal: Bioorganic & medicinal chemistry letters
Published: August 21, 2017
Comparison of Cardiovascular Parameters and Cardiac Autonomic Activity of Obese and Normal Weight School Children in Puducherry.
Journal: Indian journal of physiology and pharmacology
Published: July 01, 2016
Structure-guided discovery of 2-aryl/pyridin-2-yl-1H-indole derivatives as potent and selective hepsin inhibitors.
Journal: Bioorganic & medicinal chemistry letters
Published: July 07, 2015
Discovery of O-(3-carbamimidoylphenyl)-l-serine amides as matriptase inhibitors using a fragment-linking approach.
Journal: Bioorganic & medicinal chemistry letters
Published: September 02, 2014
Structure-guided discovery of 1,3,5 tri-substituted benzenes as potent and selective matriptase inhibitors exhibiting in vivo antitumor efficacy.
Journal: Bioorganic & medicinal chemistry
Published: March 03, 2014
X-ray structure of PTP1B in complex with a new PTP1B inhibitor.
Journal: Protein and peptide letters
Published: June 10, 2013
Discovery of 7-azaindole based anaplastic lymphoma kinase (ALK) inhibitors: wild type and mutant (L1196M) active compounds with unique binding mode.
Journal: Bioorganic & medicinal chemistry letters
Published: March 21, 2013
Showing 1-11 of 11
Last Updated: 09/26/2026